Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia

Leukemia volume 16, pages 1311–1318 (2002)Cite this article

Abstract

Absolute lymphocyte count (ALC) recovery correlates with survival after autologous hematopoietic stem cell transplantation (AHSCT) for patients with multiple myeloma, non-Hodgkin's lymphoma, and metastatic breast cancer. The role of ALC recovery in relationship to clinical outcome after AHSCT in patients with acute myelogenous leukemia is unknown. We analyzed 45 patients who underwent AHSCT at Mayo Clinic, Rochester, Minnesota between 1990 and 2000. The ALC threshold was selected at 500 cells/μl on day 15 post-AHSCT based on our previous studies. Thirty-two females and 13 males were included in the study with a median age of 45 years (range 12–75). The median follow-up was 14 months with a maximum of 129 months. The median overall and leukemia-free survival were significantly better for the 23 patients with ALC at day 15 ⩾500 cells/μl compared with 22 patients with ALC <500 cells/μl (not yet reached vs 10 months, P < 0.0009; 105 vs 9 months, P < 0.0008, respectively). In conclusion, ALC ⩾500 cells/μl on day 15 post-AHSCT is associated with better survival in acute myelogenous leukemia and requires further studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Powles R, Singhai S, Treleaven J, Kulkarni S, Horton C, Mehta J . Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation Blood 1998 91: 3481–3486

    CAS  PubMed  Google Scholar 

  2. Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC, Bierman PJ, Vose JM, Warkentin PI, Gross TG, Nasrati K, Armitage JO, Kessinger A, Bishop MR . Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematological malignancies Bone Marrow Transplant 1998 21: 33–41

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A, Gastineau DA, Dispenzieri A, Ansell SM, Micallef INM, Geyer SM, Markovic SN . Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin's lymphoma Blood 2001 98: 579–585

    Article  CAS  PubMed  Google Scholar 

  4. Porrata LF, Ingle JN, Litzow MR, Geyer SM, Markovic SN . Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer Bone Marrow Transplant 2001 28: 865–871

    Article  CAS  PubMed  Google Scholar 

  5. Mehta J, Powles R, Singhal S, Horton C, Tait D, Milan S, Meller S, Pinkerton CR, Treleaven J . Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors Bone Marrow Transplant 1995 16: 499–506

    CAS  PubMed  Google Scholar 

  6. Keating S, Suciu S, de White T, Mandelli F, Willemze R, Resegotti L, Broccia G, Thaler J, Labar B, Damasio E, Bizzi B, Rotoli B, Vekhoff A, Muus P, Petti MC, Dardenne M, Solbu G . Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 84 trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Grupp Italiano Malattie Ematologiche Maligne dell’ Adulto (GIMEMA) Leukemia Cooperative Group Bone Marrow Transplant 1996 17: 993–1001

    CAS  PubMed  Google Scholar 

  7. Harousseau JL, Cahn JY, Pignon B, Witz F, Milpied N, Delain M, Lioure B, Lamy T, Desablens B, Guilhot F, Caillot D, Abgrall JF, Francois S, Briere J, Guyotat D, Casassus P, Audhuy B, Tellier Z, Hurteloup P, Herve P . Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult myeloid leukemia. The Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM) Blood 1997 90: 2978–2986

    CAS  PubMed  Google Scholar 

  8. Ferrant A, Labopin M, Frassoni F, Prentice HG, Cahn JY, Blaise D, Reiffers J, Visani G, Sanz MA, Boogaerts MA, Lowenberg B, Gorin NC . Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation Study Blood 1997 90: 2931–2938

    CAS  PubMed  Google Scholar 

  9. Kaplan E, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  10. Cox DR . Regression models and life-tables J R Stat Soc (B) 1972 34: 187–202

    Google Scholar 

  11. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B . Graft versus leukemia reactions after bone marrow transplantation Blood 1990 75: 555–562

    CAS  PubMed  Google Scholar 

  12. Guillaume T, Rubinstein DB, Symann M . Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation Blood 1998 92: 1471–1490

    CAS  PubMed  Google Scholar 

  13. Porrata LF, Litzow MR, Markovic SN . Immune reconstitution after autologous hematopoietic stem cell transplantation Mayo Clinic Proc 2001 76: 407–412

    Article  CAS  Google Scholar 

  14. Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, Varney M, Jackson J, Vose JM, Bierman PJ . Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow Bone Marrow Transplant 1997 19: 161–172

    Article  CAS  PubMed  Google Scholar 

  15. Koehne G, Zeller W, Stockschlaeder M, Zander AR . Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1997 19: 149–156

    Article  CAS  PubMed  Google Scholar 

  16. Porrata LF, Inwards DJ, Lacy MQ, Markovic SN . Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-α in autologous stem cell transplantation Bone Marrow Transplant 2001 28: 673–680

    Article  CAS  PubMed  Google Scholar 

  17. Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE . Lymphocyte depletion during treatment with intensive chemotherapy for cancer Blood 1994 84: 2221–2228

    CAS  PubMed  Google Scholar 

  18. Kook H, Goldman F, Padley D, Giller R, Rumelhart S, Holida M, Lee N, Peters C, Comito M, Huling D, Trigg M . Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery Blood 1996 88: 1089–1097

    CAS  PubMed  Google Scholar 

  19. Dorshkind K, Pollack SB, Bosma MJ, Phillips RA . Natural killer cells are present in mice with severe combined immunodeficiency (SCID) J Immunol 1985 134: 3798–3801

    CAS  PubMed  Google Scholar 

  20. Hackett J, Bosma GC, Bosma MJ . Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes Proc Natl Acad Sci USA 1986 93: 3427–3431

    Article  Google Scholar 

  21. Lowdell MW, Wood ME, Samuel D, Craston R, Saha V, Prentice HG . Autologous leukemia-reactive CD8+NK cells are required for long-term survival after treatment for acute leukemia Blood 2000 296: 119a (Abstr. 512)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

    LF Porrata, MR Litzow, A Tefferi, L Letendre, S Kumar & SN Markovic

  2. Cancer Center Statistics, Section of Biostatistics, Mayo Clinic, Rochester, MN, USA

    SM Geyer

  3. Division of Hematology, Department of Internal Medicine, and Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN, USA

    SN Markovic

Authors
  1. LF Porrata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MR Litzow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Tefferi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L Letendre
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. SM Geyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. SN Markovic
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Porrata, L., Litzow, M., Tefferi, A. et al. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 16, 1311–1318 (2002). https://doi.org/10.1038/sj.leu.2402503

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402503

Keywords

This article is cited by

Search

Advanced search

Quick links